**Chapter 3**

*Cystic Fibrosis - Heterogeneity and Personalized Treatment*

[65] Schögler A et al. Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells. The European Respiratory Journal.

2015;**45**(2):428-439

2018;**13**(7):505-518

[66] Casanova V, Sousa FH, Stevens C, Barlow PG. Antiviral therapeutic approaches for human rhinovirus infections. Future Virology.

[67] Renk H, Regamey N, Hartl D. Influenza a(H1N1)pdm09 and cystic fibrosis lung disease: A systematic metaanalysis. PLoS One. 2014;**9**(1):e93142, 1-2. DOI: 10.1371/journal.pone.0093142

**36**
